The Effects of Aromatherapy on the Stress Levels of Nurses Working in an Urban, Safety-Net Community Hospital
NCT ID: NCT04819594
Last Updated: 2022-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
319 participants
INTERVENTIONAL
2021-06-01
2021-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effectiveness of Aromatherapy in an Urban, Safety-Net Hospital on Pain
NCT04840212
The Effect of Essential Oil Inhalation Patches on Perceived Burn-out & Stress on an Inpatient Medical-surgery Unit.
NCT06053450
Aromatherapy to Address Psychological Distress in Emergency Department Patients.
NCT07328412
Evaluation of the Efficacy of Aromatherapy on the Well-being of Healthcare Professionals
NCT05373849
The Effectiveness of Lavender Aromatherapy Combined With Slow Breathing Exercises in Improving Occupational Burnout and Sleep Disorders Among Nursing Staff
NCT06914167
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study for the participants goes as follows:
1. Nurse identified by:
* Leadership
* Self-identified
* SPARKS member
2. Process:
* Identified nurse will be informed and consented regarding the study.
* An aromatab will be given to the nurse.
* They will place the aromatab on their uniform top to allow for continuous exposure to the scent.
* Four (4) hours later - nurse completes survey as to the effects of the aromatab
* Completed survey is placed in research file at charge nurse desk in opaque folder.
Data to be used within the research project will be obtained from the collected survey forms.
Recruitment will be completed face-to-face between the SPARKS team member, leadership, or self -identification of the potential subject. Considerable care will be taken so that the person contacted does not feel pressured to participate.
The research team will meet prior to enrolling the first participant, during and upon completion of data collection. Any safety concerns will be addressed at those times. At any time during data collection, the PI's or any study team members may request that the team meets to address a safety concern. Study participants will be assured of anonymity and confidentiality of the data and they will also be reminded that they can withdraw from the study at any time.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study Group
Nurses will wear the Elequil aromatabs ® (100% pure essential oil) over a four-hour period
Elequil aromatabs ®
100% pure essential oils in a unique controlled delivery system for relaxation, comfort, and sleep. Scented tabs on a self-adhesive label will be placed on the nurses's uniform for 4 hours to provide aromatherapy for the clinical setting.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Elequil aromatabs ®
100% pure essential oils in a unique controlled delivery system for relaxation, comfort, and sleep. Scented tabs on a self-adhesive label will be placed on the nurses's uniform for 4 hours to provide aromatherapy for the clinical setting.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Parkland Health and Hospital System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Justin Buchert
Quality Specialist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Justin Buchert, MSN, M.Ed., MS, RN
Role: PRINCIPAL_INVESTIGATOR
Parkland Health and Hospital System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Parkland Health and Hospital System
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU-2020-1413
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.